1.09
+0.106(+10.77%)
Currency In USD
| Previous Close | 0.98 |
| Open | 0.99 |
| Day High | 1.11 |
| Day Low | 0.99 |
| 52-Week High | 3.94 |
| 52-Week Low | 0.82 |
| Volume | 5.51M |
| Average Volume | 4.42M |
| Market Cap | 215.98M |
| PE | -3.89 |
| EPS | -0.28 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.93 |
| Change | 0.11 |
If you invested $1000 in Esperion Therapeutics, Inc. (ESPR) 10 years ago, it would be worth $10.5 as of May 03, 2025 at a share price of $1.09. Whereas If you bought $1000 worth of Esperion Therapeutics, Inc. (ESPR) shares 5 years ago, it would be worth $27.68 as of May 03, 2025 at a share price of $1.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Esperion to Participate in The Citizens Life Sciences Conference
GlobeNewswire Inc.
Apr 25, 2025 12:00 PM GMT
ANN ARBOR, Mich., April 25, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted Citizens Life Sciences Conference on May 8, 2025, at 12:30 p.m. ET. The live webcast can be accesse
Esperion Unveils Promising Research Supporting Lead Development Candidates for Primary Sclerosing Cholangitis (PSC) at R&D Day 2025
GlobeNewswire Inc.
Apr 24, 2025 12:00 PM GMT
– Expands Development Portfolio with Introduction of a Novel Program Targeting PSC – – Confirms Highly Specific Allosteric ACLY Inhibitor Shown to Reduce Liver Injury, Inflammation and Fibrosis Across Multiple PSC-Relevant Pre-Clinical Models – – Dem
Esperion to Report First Quarter 2025 Financial Results on May 6
GlobeNewswire Inc.
Apr 23, 2025 12:00 PM GMT
ANN ARBOR, Mich., April 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. Following the release, management will host a webcast